Protective Effect Of Vasicine Against Myocardial Infarction In Rats Via Modulation Of Oxidative Stress, Inflammation, And The PI3K/Akt Pathway

References

• Yusuf PS, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–952. doi:10.1016/S0140-6736(04)17018-915364185
   PubMed Web of Science ®Google Scholar
• Roger VL. Epidemiology of myocardial infarction. Med Clin North Am. 2007;91(4):537–552. doi:10.1016/j.mcna.2007.03.00717640535
   PubMed Web of Science ®Google Scholar
• Strange J, Knight C. Management of acute myocardial infarction. Medicine (Baltimore). 2006;34(5):188–194. doi:10.1383/medc.2006.34.5.188
   Google Scholar
• Rischpler C. A cute myocardial infarction. Q J Nucl Med Mol Imaging. 2016;60(3):236–251.27225319
   PubMed Web of Science ®Google Scholar
• Steg PG, James SK, Atar D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–2619. doi:10.1093/eurheartj/ehs21522922416
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119–177. doi:10.1093/eurheartj/ehx39328886621
   PubMed Web of Science ®Google Scholar
• Harrington RA. Myocardial ischemia and infarction. J Am Coll Cardiol. 2004;44:S10–S12. doi:10.1016/j.jacc.2004.06.025
   PubMed Web of Science ®Google Scholar
• Fisher SA, Zhang H, Doree C, Mathur A, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2015;2015(9). doi:10.1002/14651858.CD006536.pub4
   PubMed Web of Science ®Google Scholar
• Reddy K. Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol. 2015;7(5):243. doi:10.4330/wjc.v7.i5.24326015857
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92–100. doi:10.1172/JCI6287423281415
   PubMed Web of Science ®Google Scholar
• Van Den Borne SWM, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol. 2010;7(1):30–37. doi:10.1038/nrcardio.2009.19919949426
   PubMed Web of Science ®Google Scholar
• Hofmann R, James SK, Jernberg T, et al. Oxygen therapy in suspected acute myocardial infarction. N Engl J Med. 2017;377(13):1240–1249. doi:10.1056/NEJMoa170622228844200
   PubMed Web of Science ®Google Scholar
• Ceballos RLA. Use of herbal medicines and implications for conventional drug therapy medical sciences. Altern Integr Med. 2013;02:06. doi:10.4172/2327-5162.1000130
   Google Scholar
• Chaudhury R, Rafei U. Traditional Medicine in Asia. South-East Asia, New Delhi: SEARO; 2001:23 Available from: http://searo.who.int/entity/medicines/documents/traditional_medicines_in_asia.pdf Accessed 103, 2019.
   Google Scholar
• Sumanth M. Screening of beetroot juice for anticancer acivity. World J Pharm Res. 2016;5(6):861–870. doi:10.20959/wjpr20168-6435
   Google Scholar
• Robinson MM, Zhang X. The World Medicines Situation 2011 Traditional Medicines : Global Situation, Issues and Challenges. World Health Organization; 2011:1–14.
   Google Scholar
• Nepali K, Sharma S, Ojha R, Dhar KL. Vasicine and structurally related quinazolines. Med Chem Res. 2013;22(1):1–15. doi:10.1007/s00044-012-0002-5
   Web of Science ®Google Scholar
• Ali SK, Hamed AR, Soltan MM, El-Halawany AM, Hegazy UM, Hussein AA. Kinetics and molecular docking of vasicine from Adhatoda vasica: an acetylcholinesterase inhibitor for Alzheimer’s disease. South African J Bot. 2016;104:118–124. doi:10.1016/j.sajb.2015.09.021
   Web of Science ®Google Scholar
• Zhao T, Ding KM, Zhang L, Cheng XM, Wang CH, Wang ZT. Acetylcholinesterase and butyrylcholinesterase inhibitory activities of β -carboline and quinoline alkaloids derivatives from the plants of genus peganum. J Chem. 2013. doi:10.1155/2013/717232
   Web of Science ®Google Scholar
• Singh B, Sharma RA. Anti-inflammatory and antimicrobial properties of pyrroloquinazoline alkaloids from Adhatoda vasica Nees. Phytomedicine. 2013;20(5):441–445. doi:10.1016/j.phymed.2012.12.01523357363
   PubMed Web of Science ®Google Scholar
• Shahwar D, Raza MA, Tariq S, Riasat M, Ajaib M. Enzyme inhibition, antioxidant and antibacterial potential of vasicine isolated from Adhatoda vasica Nees. Pak J Pharm Sci. 2012;25(3):651–656.22713956
   PubMed Web of Science ®Google Scholar
• Liu W, Cheng X, Wang Z, Wang C. The research progress of vasicine resources, pharmacological activities, pharmacokinetics, toxicity and analysis methods. Guoji Yaoxue Yanjiu Zazhi. 2013;40(4):386–395.
   Google Scholar
• Gupta OP, Anand KK, Ray Ghatak BJ, Atal CK. Vasicine, alkaloid of Adhatoda vasica, a promising uterotonic abortifacient. Indian J Exp Biol. 1978;16(10):1075–1077.750386
   PubMed Web of Science ®Google Scholar
• Chandokhe N, Gupta OP, Atal CK. Abortifacient activity of the alkaloid vasicine through the release of prostaglandins. J Steroid Biochem. 1978;9(9):885. doi:10.1016/0022-4731(78)91053-1
   Google Scholar
• Hertog MGL, Feskens EJM, Kromhout D, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342(8878):1007–1011. doi:10.1016/0140-6736(93)92876-U8105262
   PubMed Web of Science ®Google Scholar
• Ye Y, Li J, Yuan Z. Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One. 2013;8:2. doi:10.1371/journal.pone.0056803
   Web of Science ®Google Scholar
• Asplund K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med. 2002;251(5):372–392. doi:10.1046/j.1365-2796.2002.00973.x11982737
   PubMed Web of Science ®Google Scholar
• Dong LY, Yao LP, Zhao J, Jin KK, Qiu XX. Captopril inhibits calpain-mediated apoptosis of myocardial cells in diabetic rats and improves cardiac function. Mol Med Rep. 2018;18(2):2300–2306. doi:10.3892/mmr.2018.919229956776
   PubMed Web of Science ®Google Scholar
• Chen H, Xu Y, Wang J, Zhao W, Ruan H. Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation and oxidative stress in rat. Int J Clin Exp Pathol. 2015;8(9):10139–10147.26617721
   PubMed Web of Science ®Google Scholar
• Ma C, Jiang Y, Zhang X, Chen X, Liu Z, Tian X. Isoquercetin ameliorates myocardial infarction throughanti-inflammation and anti-Apoptosis factor and regulating TLR4-NF-B signal pathway. Mol Med Rep. 2018;17(5):6675–6680. doi:10.3892/mmr.2018.870929532872
   PubMed Web of Science ®Google Scholar
• Liu J, Wang H, Wang Y, et al. The stem cell adjuvant with Exendin-4 repairs the heart after myocardial infarction via STAT3 activation. J Cell Mol Med. 2014;18(7):1381–1391. doi:10.1111/jcmm.1227224779911
   PubMed Web of Science ®Google Scholar
• Claeson UP, Malmfors T, Wikman G, Bruhn JG. Adhatoda vasica: a critical review of ethnopharmacological and toxicological data. J Ethnopharmacol. 2000;72(1–2):1–20. doi:10.1016/S0378-8741(00)00225-710967448
   PubMed Web of Science ®Google Scholar
• Gangwar AK, Ghosh AK. Medicinal uses and pharmacological activity of Adhatoda vasica. Int J Herb Med. 2014;2(1):88–91.
   Google Scholar
• Anand Kumar G. Biomarkers in acute myocardial infarction. Natl J Basic Med Sci. 2018;8(3):137–141. doi:10.31975/njbms.2018.8303
   Google Scholar
• Tanwar V, Sachdeva J, Kishore K, et al. Dose-dependent actions of curcumin in experimentally induced myocardial necrosis: a biochemical, histopathological, and electron microscopic evidence. Cell Biochem Funct. 2010;28(1):74–82. doi:10.1002/cbf.162320029958
   PubMed Web of Science ®Google Scholar
• Kehl DW, Iqbal N, Fard A, Kipper BA, De La Parra Landa A, Maisel AS. Biomarkers in acute myocardial injury. Transl Res. 2012;159(4):252–264. doi:10.1016/j.trsl.2011.11.00222424429
   PubMed Web of Science ®Google Scholar
• Omland T, Pfeffer MA, Solomon SD, et al. Prognostic value of cardiac troponin i measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;61(12):1240–1249. doi:10.1016/j.jacc.2012.12.02623414791
   PubMed Web of Science ®Google Scholar
• James SK, Armstrong P, Barnathan E, et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: A. GUSTO-IV Substudy. J Am Coll Cardiol. 2003;41(6):916–924. doi:10.1016/S0735-1097(02)02969-812651034
   PubMed Web of Science ®Google Scholar
• Timmers L, Lim SK, Arslan F, et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 2008;1(2):129–137. doi:10.1016/j.scr.2008.02.002
   Web of Science ®Google Scholar
• Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010;121(22):2437–2445. doi:10.1161/CIRCULATIONAHA.109.91634620530020
   PubMed Web of Science ®Google Scholar
• Kosmala W, Przewlocka-Kosmala M, Mazurek W. Proinflammatory cytokines and myocardial viability in patients after acute myocardial infarction. Int J Cardiol. 2005;101:449–456. doi:10.1016/j.ijcard.2004.03.06715907414
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53(1):31–47. doi:10.1016/S0008-6363(01)00434-511744011
   PubMed Web of Science ®Google Scholar
• Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res. 2009;81(3):457–464. doi:10.1093/cvr/cvn33519047340
   PubMed Web of Science ®Google Scholar
• Hashmi S, Al-Salam S. Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison. Int J Clin Exp Pathol. 2015;8(8):8786–8796.26464621
   PubMed Web of Science ®Google Scholar
• Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med. 2000;109(4):315–323. doi:10.1016/S0002-9343(00)00467-810996583
   PubMed Web of Science ®Google Scholar
• Patel V, Upaganlawar A, Zalawadia R, Balaraman R. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol. 2010;644(1–3):160–168. doi:10.1016/j.ejphar.2010.06.06520624385
   PubMed Web of Science ®Google Scholar
• Surekha RH, Srikanth BBM V, Jharna P, Ramachandra RV, Dayasagar RV, Jyothy A. Oxidative stress and total antioxidant status in myocardial infarction. Singapore Med J. 2007;48(2):137–142.17304393
   PubMedGoogle Scholar
• Rodrigo R, Libuy M, Feliú F, Hasson D. Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarction. Biomed Res Int. 2013;2013:1–15. doi:10.1155/2013/437613
   Web of Science ®Google Scholar
• Roja G, Vikrant BH, Sandur SK, Sharma A, Pushpa KK. Accumulation of vasicine and vasicinone in tissue cultures of Adhatoda vasica and evaluation of the free radical-scavenging activities of the various crude extracts. Food Chem. 2011;126(3):1033–1038. doi:10.1016/j.foodchem.2010.11.115
   Web of Science ®Google Scholar
• Liu W, Wang Y, He DD, et al. Antitussive, expectorant, and bronchodilating effects of quinazoline alkaloids (±)-vasicine, deoxyvasicine, and (±)-vasicinone from aerial parts of Peganum harmala L. Phytomedicine. 2015;22(12):1088–1095. doi:10.1016/j.phymed.2015.08.00526547531
   PubMed Web of Science ®Google Scholar
• Muslin AJ. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci. 2008;115(7–8):203–218. doi:10.1042/CS2007043018752467
   PubMed Web of Science ®Google Scholar
• Tanno M, Bassi R, Gorog DA, et al. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res. 2003;93(3):254–261. doi:10.1161/01.RES.0000083490.43943.8512829618
   PubMed Web of Science ®Google Scholar
• Clark JE, Sarafraz N, Marber MS. Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. Pharmacol Ther. 2007;116(2):192–206. doi:10.1016/j.pharmthera.2007.06.01317765316
   PubMed Web of Science ®Google Scholar
• Ren J, Zhang S, Kovacs A, Wang Y, Muslin AJ. Role of p38α MAPK in cardiac apoptosis and remodeling after myocardial infarction. J Mol Cell Cardiol. 2005;38(4):617–623. doi:10.1016/j.yjmcc.2005.01.01215808838
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Glob Heart. 2012;7(4):275–295. doi:10.1016/j.gheart.2012.08.00125689940
   PubMedGoogle Scholar
• Konstantinidis K, Whelan RS, Kitsis RN. Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc Biol. 2012;32(7):1552–1562. doi:10.1161/ATVBAHA.111.22491522596221
   PubMed Web of Science ®Google Scholar
• Whelan RS, Kaplinskiy V, Kitsis RN. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol. 2010;72(1):19–44. doi:10.1146/annurev.physiol.010908.16311120148665
   PubMed Web of Science ®Google Scholar
• Kis A, Yellon DM, Baxter GF. Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. J Mol Cell Cardiol. 2003;35(9):1063–1071. doi:10.1016/S0022-2828(03)00208-612967629
   PubMed Web of Science ®Google Scholar
• Gallo S, Sala V, Gatti S, Crepaldi T. Cellular and molecular mechanisms of HGF/Met in the cardiovascular system. Clin Sci. 2015;129(12):1173–1193. doi:10.1042/CS2015050226561593
   PubMed Web of Science ®Google Scholar
• Krijnen PAJ, Nijmeijer R, Meijer CJLM, Visser CA, Hack CE, Niessen HWM. Apoptosis in myocardial ischaemia and infarction. J Clin Pathol. 2002;55(11):801–811. doi:10.1136/jcp.55.11.80112401816
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Pathophysiology of myocardial infarction. Compr Physiol. 2015;5(4):1841–1875. doi:10.1002/cphy.c15000626426469
   PubMed Web of Science ®Google Scholar
• Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation. 1997;95(2):320–323. doi:10.1161/01.CIR.95.2.3209008443
   PubMed Web of Science ®Google Scholar
• Li W, Ma N, Ong -L-L, et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells. 2007;25(8):2118–2127. doi:10.1634/stemcells.2006-077117478584
   PubMed Web of Science ®Google Scholar
• Brady NR, Hamacher-Brady A, Gottlieb RA. Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim Biophys Acta Bioenerg. 2006;1757(5–6):667–678. doi:10.1016/j.bbabio.2006.04.011
   Web of Science ®Google Scholar
• Cassidy-Stone A, Chipuk JE, Ingerman E, et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell. 2008;14(2):193–204. doi:10.1016/j.devcel.2007.11.01918267088
   PubMed Web of Science ®Google Scholar
• Toldo S, Abbate A. The NLRP3 inflammasome in acute myocardial infarction. Nat Rev Cardiol. 2018;15(4):203–214. doi:10.1038/nrcardio.2017.16129143812
   PubMed Web of Science ®Google Scholar